Genocea Biosciences, Inc. (GNCA) Narrows Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts GNCA Hot Sheet
Join SI Premium – FREE
Genocea Biosciences, Inc. (NASDAQ: GNCA) reported Q1 EPS of ($0.76), versus ($17.09) reported last year. Revenue for the quarter came in at $0 , versus $259 thousand reported last year.
For earnings history and earnings-related data on Genocea Biosciences, Inc. (GNCA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AIR Global sets first-ever dividend, $100M buyback amid business, cash strength
- Q.e.p. Co., Inc. (QEPC) Tops Q2 EPS by 197c
- Interactive Brokers (IBKR) Reports In-Line Q3 EPS, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
